The brain is a notoriously difficult organ to treat, but Johns Hopkins researchers report they are one step closer to having a drug-delivery system flexible enough to overcome some key challenges posed by ...
Sep 11, 2012
5 / 5 (5)
2
|
A small slice of RNA inhibits prostate cancer metastasis by suppressing a surface protein commonly found on prostate cancer stem cells. A research team led by scientists at The University of Texas MD Anderson Cancer Center ...
Jan 16, 2011
4.1 / 5 (7)
0
|
Building on his Nobel Prize-winning work creating fluorescent proteins that light up the inner workings of cells, a team of researchers led by Howard Hughes Medical Institute investigator Roger Tsien, PhD, professor of pharmacology, ...
Feb 16, 2010
4 / 5 (1)
0
|
A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical ...
Oct 19, 2009
5 / 5 (4)
1
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. ...
Jan 31, 2012
5 / 5 (2)
0
(PhysOrg.com) -- Even in the early stages of cancer, individual cancer cells can be found in the blood. Certain subsets of these circulating tumor cells can cause metastasis. In cases of breast cancer, it ...
Mar 02, 2012
5 / 5 (1)
0
According to a recent study, there is a new mechanism of drug release using 3D superhydrophobic materials that utilizes air as a removable barrier to control the rate at which drug is released.
Jan 27, 2012
not rated yet
0
(PhysOrg.com) -- A team of Northwestern University researchers, using an extremely sensitive nanotechnology-based tool known as the biobarcode system, has detected previously undetectable levels of prostate-specific antigen ...
Nov 18, 2009
4 / 5 (1)
1
In a research article published in this week's PLoS Medicine, Ann Killary (from the University of Texas M. D. Anderson Cancer Center) and colleagues describe a new gene called DEAR1 that is genetically altered by mutation and de ...
May 05, 2009
not rated yet
0
Most women face only a small risk of breast cancer coming back after they complete their treatment. Yet a new study from the University of Michigan Comprehensive Cancer Center finds that nearly half of Latinas who speak little ...
Mar 28, 2011
not rated yet
0
A new gene test may help predict which colon cancer patients are at higher or lower risk of having their cancer return after surgery, doctors report, but whether it is useful enough to justify its likely high price remains ...
May 14, 2009
not rated yet
0
University of Cincinnati (UC) Cancer Institute oncologists are testing whether a widely used cholesterol-reducing drug can help prevent the recurrence of colorectal cancer in patients who have been surgically ...
Mar 02, 2011
4 / 5 (1)
0
Connie Krabbe understands the fear and foreboding breast cancer survivors feel when visiting their physicians for post-treatment check-ups. Two of her four sisters died of metastatic cancer related to breast ...
Oct 20, 2010
2 / 5 (1)
0
Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October ...
Oct 11, 2010
not rated yet
0
In the Life After Cancer Epidemiology (LACE) study, 1,897 participants diagnosed with early-stage breast cancer between 1997 and 2000 and recruited on average 2 years post-breast cancer diagnosis were evaluated for the association ...
Sep 15, 2010
not rated yet
0
